Author

D. Deming

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:deep learning· 1 Organism:human· 1 Assay:imaging· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

A. Alam· 1 shared A. J. Asakawa· 1 shared C. C. Siska· 1 shared C. Carbonelle· 1 shared C. Moldovan Loomis· 1 shared D. A. Gil· 1 shared D. Van Citters· 1 shared G. Neveu· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Alam

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

AI-based antibody discovery platform identifies novel, diverse and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strains

C. Moldovan Loomis, T. Lahlali, D. Van Citters, M. Sprague, G. Neveu, L. Somody, C. C. Siska, D. Deming, A. J. Asakawa, T. Amimeur, J. M. Shaver, C. Carbonelle, R. R. Ketchem, A. Alam, R. H. Clark

This paper presents an AI-based platform for rapid antibody discovery against SARS-CoV-2, identifying novel therapeutic antibodies effective against multiple strains.

bioRxiv · Aug 21, 2023 · PreprintImmunology

Patient-derived cancer organoid tracking with widefield one-photon redox imaging to assess treatment response

D. A. Gil, D. Deming, M. C. Skala

This study uses redox imaging to track individual cancer organoids and assess treatment response by measuring metabolic and morphological changes.

bioRxiv · Dec 19, 2020Bioengineering